BLIFASEND Trademark

Trademark Overview


On Wednesday, March 26, 2025, a trademark application was filed for BLIFASEND with the United States Patent and Trademark Office. The USPTO has given the BLIFASEND trademark a serial number of 99105159. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 16, 2025. This trademark is owned by Glaxo Group Limited. The BLIFASEND trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
blifasend

General Information


Serial Number99105159
Word MarkBLIFASEND
Filing DateWednesday, March 26, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Wednesday, March 26, 2025NEW APPLICATION ENTERED
Wednesday, March 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 26, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 7, 2025ASSIGNED TO EXAMINER
Friday, August 8, 2025LETTER OF SUSPENSION E-MAILED
Thursday, August 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 14, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 8, 2025SUSPENSION LETTER WRITTEN
Friday, August 8, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED